Acabrunat - Acalabrutinib 100mg 30 Capsules (Calquence) - Blood Cancer Medication

ACALABRUTINIB 100 mg (Acabrunat) x 30 Capsules

$550.00 $230.00
image Prescription Required

Acabrunat Acalabrutinib 100 mg Capsules are an oral targeted therapy used for the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).

Generic Name Acalabrutinib
Manufacturer Natco
Packing 30 Capsules
Prescribed For Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Availability In Stock
Shipping to USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries.

Contact us on WhatsApp

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Benefits of ACALABRUTINIB 100 mg

  • Helps treat certain types of lymphoma
  • Supports advanced blood cancer care
  • Targets and slows cancer progression
  • Used in precision cancer treatment
  • May improve treatment response
  • Supports ongoing oncology management

Side effects

  • Headache
  • Fatigue
  • Nausea
  • Diarrhea
  • Muscle or joint pain
  • Bruising or bleeding
  • Low red or white blood cell count
  • Cough
  • Infections (especially respiratory)

Caution:

  • Take as prescribed.
  • Do not skip or stop doses.
  • Inform your doctor of heart, liver, or kidney issues.
  • Monitor blood counts and liver function.
  • Avoid grapefruit or grapefruit juice.
  • Do not share medication.
  • Store in a cool, dry place away from children.

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.

Author

Reviewed By

Dr. Abhinav Narang

Doctor of Medicine (MD) | Professional Interest in Oncology

Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.

Need assistance? Chat with us